-
1
-
-
33847707734
-
Stent thrombosis redux - The FDA perspective
-
DOI 10.1056/NEJMp068304
-
Farb A, Boam AB. Stent thrombosis redux. The FDA perspective. N Engl J Med. 2007; 356: 984-987. (Pubitemid 46376798)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.10
, pp. 984-987
-
-
Farb, A.1
Boam, A.B.2
-
2
-
-
34247092074
-
Thrombosis of drug-eluting stents: Fact or fiction?
-
Katritsis DG. Thrombosis of drug-eluting stents: fact or fiction? Hellenic J Cardiol. 2006; 47: 324-328.
-
(2006)
Hellenic J Cardiol
, vol.47
, pp. 324-328
-
-
Katritsis, D.G.1
-
3
-
-
51649119808
-
Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-Year results from a large 2-institutional cohort study
-
Wenaweser P, Daemen J, Zwahlen M, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol. 2008; 52: 1134-1140.
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 1134-1140
-
-
Wenaweser, P.1
Daemen, J.2
Zwahlen, M.3
-
4
-
-
11144356029
-
Stent Thrombosis after Successful Sirolimus-Eluting Stent Implantation
-
DOI 10.1161/01.CIR.0000127105.99982.21
-
Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation. 2004; 109: 1930-1932. (Pubitemid 38544480)
-
(2004)
Circulation
, vol.109
, Issue.16
, pp. 1930-1932
-
-
Jeremias, A.1
Sylvia, B.2
Bridges, J.3
Kirtane, A.J.4
Bigelow, B.5
Pinto, D.S.6
Ho, K.K.L.7
Cohen, D.J.8
Garcia, L.A.9
Cutlip, D.E.10
Carrozza Jr., J.P.11
-
5
-
-
2342645995
-
Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients
-
DOI 10.1016/j.amjcard.2004.02.013, PII S0002914904002280
-
Regar E, Lemos PA, Saia F, et al. Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients. Am J Cardiol. 2004; 93: 1271-1275. (Pubitemid 38595682)
-
(2004)
American Journal of Cardiology
, vol.93
, Issue.10
, pp. 1271-1275
-
-
Regar, E.1
Lemos, P.A.2
Saia, F.3
Degertekin, M.4
Tanabe, K.5
Lee, C.-H.6
Arampatzis, C.A.7
Hoye, A.8
Sianos, G.9
De Feyter, P.10
Van Der Giessen, W.J.11
Smits, P.C.12
Van Domburg, R.T.13
Serruys, P.W.14
-
6
-
-
21244489021
-
Very late thrombosis after implantation of sirolimus eluting stent
-
Karvouni E, Korovesis S, Katritsis DG. Very late thrombosis after implantation of sirolimus eluting stent. Heart. 2005; 91: e45.
-
(2005)
Heart
, vol.91
-
-
Karvouni, E.1
Korovesis, S.2
Katritsis, D.G.3
-
7
-
-
49349114160
-
Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents
-
Gori AM, Marcucci R, Migliorini A, et al. Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents. J Am Coll Cardiol. 2008; 52: 734-739.
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 734-739
-
-
Gori, A.M.1
Marcucci, R.2
Migliorini, A.3
-
8
-
-
38649141519
-
Resistance to aspirin and clopidogrel: Possible mechanisms, laboratory investigation, and clinical significance
-
Papathanasiou A, Goudevenos J, Tselepis AD. Resistance to aspirin and clopidogrel: possible mechanisms, laboratory investigation, and clinical significance. Hellenic J Cardiol. 2007; 48: 352-363. (Pubitemid 351170746)
-
(2007)
Hellenic Journal of Cardiology
, vol.48
, Issue.6
, pp. 352-363
-
-
Papathanasiou, A.1
Goudevenos, J.2
Tselepis, A.D.3
-
9
-
-
42149119040
-
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITONTIMI 38 trial: A subanalysis of a randomised trial
-
TRITONTIMI 38 Investigators
-
Wiviott SD, Braunwald E, McCabe CH, et al; TRITONTIMI 38 Investigators. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITONTIMI 38 trial: a subanalysis of a randomised trial. Lancet. 2008; 371: 1353-1363.
-
(2008)
Lancet
, vol.371
, pp. 1353-1363
-
-
Wiviott, S.D.1
Braunwald, E.2
McCabe, C.H.3
-
10
-
-
10744229988
-
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious?
-
Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004; 109: r8-r42.
-
(2004)
Circulation
, vol.109
-
-
Virmani, R.1
Guagliumi, G.2
Farb, A.3
-
11
-
-
0037137302
-
Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans
-
DOI 10.1161/01.CIR.0000041632.02514.14
-
Virmani R, Liistro F, Stankovic G, et al. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation. 2002; 106: 2649-2651. (Pubitemid 35364917)
-
(2002)
Circulation
, vol.106
, Issue.21
, pp. 2649-2651
-
-
Virmani, R.1
Liistro, F.2
Stankovic, G.3
Di Mario, C.4
Montorfano, M.5
Farb, A.6
Kolodgie, F.D.7
Colombo, A.8
-
12
-
-
0141885290
-
Pathological mechanisms of fatal late coronary stent thrombosis in humans
-
DOI 10.1161/01.CIR.0000091115.05480.B0
-
Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation. 2003; 108: 1701-1706. (Pubitemid 37243657)
-
(2003)
Circulation
, vol.108
, Issue.14
, pp. 1701-1706
-
-
Farb, A.1
Burke, A.P.2
Kolodgie, F.D.3
Virmani, R.4
-
13
-
-
42949138867
-
Balancing the Risks of Restenosis and Stent Thrombosis in Bare-Metal Versus Drug-Eluting Stents. Results of a Decision Analytic Model
-
DOI 10.1016/j.jacc.2008.01.042, PII S0735109708007742
-
Garg P, Cohen DJ, Gaziano T, Mauri L. Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model. J Am Coll Cardiol. 2008; 51: 1844-1853. (Pubitemid 351615257)
-
(2008)
Journal of the American College of Cardiology
, vol.51
, Issue.19
, pp. 1844-1853
-
-
Garg, P.1
Cohen, D.J.2
Gaziano, T.3
Mauri, L.4
-
14
-
-
13844272022
-
Meta-analysis comparing drug-eluting stents with bare metal stents
-
DOI 10.1016/j.amjcard.2004.10.041
-
Katritsis DG, Karvouni E, Ioannidis JP. Meta-analysis comparing drug-eluting stents with bare metal stents. Am J Cardiol. 2005; 95: 640-643. (Pubitemid 40255258)
-
(2005)
American Journal of Cardiology
, vol.95
, Issue.5
, pp. 640-643
-
-
Katritsis, D.G.1
Karvouni, E.2
Ioannidis, J.P.A.3
-
15
-
-
34548542073
-
Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis
-
DOI 10.1016/S0140-6736(07)61444-5, PII S0140673607614445
-
Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007; 370: 937-948. (Pubitemid 47393576)
-
(2007)
Lancet
, vol.370
, Issue.9591
, pp. 937-948
-
-
Stettler, C.1
Wandel, S.2
Allemann, S.3
Kastrati, A.4
Morice, M.C.5
Schomig, A.6
Pfisterer, M.E.7
Stone, G.W.8
Leon, M.B.9
De Lezo, J.S.10
Goy, J.-J.11
Park, S.-J.12
Sabate, M.13
Suttorp, M.J.14
Kelbaek, H.15
Spaulding, C.16
Menichelli, M.17
Vermeersch, P.18
Dirksen, M.T.19
Cervinka, P.20
Petronio, A.S.21
Nordmann, A.J.22
Diem, P.23
Meier, B.24
Zwahlen, M.25
Reichenbach, S.26
Trelle, S.27
Windecker, S.28
Juni, P.29
more..
|